SocietyReporters | Welcome to SocietyReporters.com …News as it happens!!!

The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians to the recall of Dove beauty bar soap.

 

In a statement on Monday, Mojisola Adeyeye, the NAFDAC director-general, said the 100g soap with batch number 81832M 08, produced in Germany, was recalled due to chemical impurity.

 

Adeyeye said the soap does not comply with the cosmetic products regulations because it contains butylphenyl methylpropional (BMHCA), which is prohibited due to its risk of harming the reproductive system, causing harm to the health of an unborn child, and skin sensitisation.

 

“As a result, a ban on the marketing of the product has been placed by some regulatory and public authorities in the EU,” the statement reads.

 

”Other Dove cosmetic products recalled/banned in other countries due to the presence of BMHCA are Derma Spa Goodness, Men Care, Men Care+ Sensitive Shield, Natural Touch, Nourishing Body Care Light Hydro, Pampering Body Lotion, Go Fresh, Talco con Crema, Go Fresh Pera, Extra Fresh, Goodness3 Skincare Ritual, invisible dry antiperspirant spray + Go Fresh Revitalize nourishing shower gel, Caring hand wash, and invisible dry.

 

“Importation of soaps is prohibited in Nigeria as per the restricted and import prohibition list.

 

“Beyond the import restrictions, soaps and cosmetics are parts of the items ineligible for foreign exchange to import in Nigeria.

 

These products are also not available in the NAFDAC database.

 

“Importers, distributors, retailers, and consumers are advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of the above-mentioned products.

 

“Members of the public in possession of the product should discontinue the sale or use and submit stock to the nearest NAFDAC office.

 

“Healthcare professionals and consumers are encouraged to report adverse events experienced with the use of regulated products to the nearest NAFDAC office, via pharmacovigilance@nafdac.gov.ng, e-reporting platforms available at www.nafdac.gov.ng, or via the Med-Safety application for download on android and IOS stores.”

Exit mobile version